Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Irum Khan"'
Autor:
Ivy Elizabeth, Abraham, Anand Ashwin, Patel, Heidy, Wang, John Patrick, Galvin, Olga, Frankfurt, Li, Liu, Irum, Khan
Publikováno v:
Cancer causescontrol : CCC. 32(7)
Racial disparities in acute myeloid leukemia (AML) have been reported but the relative contribution of disease versus patient-specific factors including comorbidities and access to care is unclear.We conducted a retrospective analysis of patient char
Autor:
Victor R. Gordeuk, Damiano Rondelli, John G. Quigley, Yi Fan Chen, Ronald Hoffman, David Peace, Irum Khan, Pritesh R. Patel, Santosh L. Saraf, Ardaman Shergill
Publikováno v:
Clinical lymphoma, myelomaleukemia. 16(6)
Background The Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) are characterized by an increased risk of thrombotic and hemorrhagic complications. Large retrospective studies have demonstrated racial disparities in MPN outcomes a
Autor:
Monika J. Stankiewicz, Priya Koppikar, Brady L. Stein, Lauren Diebold, Qiang Wen, Ross L. Levine, Terra L. Lasho, Zan Huang, Sandeep Gurbuxani, Benjamin Goldenson, Ayalew Tefferi, Animesh Pardanani, Christy Finke, John D. Crispino, Rachael Schultz, Irum Khan, Jessica K. Altman, Laure Gilles
Publikováno v:
Leukemia
The majority of patients with BCR-ABL1-negative myeloproliferative neoplasms (MPN) harbor mutations in JAK2 or MPL, which lead to constitutive activation of the JAK/STAT, PI3K, and ERK signaling pathways. JAK inhibitors by themselves are inadequate i